Souders Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Souders Financial Advisors's PFE Position: Q2 2026 in Review
Souders Financial Advisors reduced its Pfizer (PFE) stake by 0.23% in Q2 2026, selling an estimated $628 and leaving 10,245 shares worth $247K. The position accounts for 0.02% of the portfolio, ranked #209.
Souders Financial Advisors first reported a position in PFE in Q1 2020 and has held it in 25 quarters since. The position peaked at $4.44M in Q4 2021. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Souders Financial Advisors held 10,245 shares of Pfizer worth $247K as of Q2 2026.
- Souders Financial Advisors sold 24 Pfizer shares in Q2 2026, an estimated $628.
- Pfizer made up 0.02% of Souders Financial Advisors's portfolio in Q2 2026, its #209 holding.
- Souders Financial Advisors first reported a position in Pfizer in Q1 2020 and has held it in 25 quarters since.
- Souders Financial Advisors's Pfizer position peaked at $4.44M in Q4 2021.
- 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Souders Financial Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.